Author:
Xia Qi,Deng An-mei,Wu Shan-shan,Zheng Min
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference28 articles.
1. Parkin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74–108.
2. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD . Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353–67.
3. Greten TF, Korangy F, Manns MP, Malek NP . Molecular therapy for the treatment of hepatocellular carcinoma. Br J Cancer 2009; 100: 19–23.
4. Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Graur F, Cristea V, et al. Hepatocellular carcinoma: tumorigenesis and prediction markers. Gastroenterol Res 2009; 2: 191–9.
5. Cooper AB, Wu J, Lu D, Maluccio MA . Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J Gastrointest Surg 2007; 11: 1628–34.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献